Section Arrow
Quote
MASS.NASDAQ
- 908 Devices
Quotes are at least 15-min delayed:2026/04/29 04:28 EDT
Pre Market
Last
 6.74
0 (0.00%)
Bid
6.74
Ask
7.79
High 6.74 
Low 6.61 
Volume 32 
Regular Hours (Closed)
Last
 6.74
0 (0.00%)
Day High 
6.78 
Prev. Close
6.74 
1-M High
7.72 
Volume 
196.56K 
Bid
6.74
Ask
7.79
Day Low
6.6 
Open
6.67 
1-M Low
5.7 
Market Cap 
251.94M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 7.12 
20-SMA 6.89 
50-SMA 6.61 
52-W High 9.34 
52-W Low 4.2 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.54/--
Enterprise Value
255.89M
Balance Sheet
Book Value Per Share
3.84
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
56.20M
Operating Revenue Per Share
1.27
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
PFSAProfusa Inc.0.5553+0.0422+8.22%-- 
Pre Market 0.5471 -0.0082 -1.48%
BSXBoston Scientific Corp58.45-1.5-2.50%30.9PE
Pre Market 58.54 +0.09 +0.15%
ABTAbbott Laboratories93.86+1.06+1.14%24.95PE
Pre Market 94.2838 +0.4238 +0.45%
MDTMedtronic plc81.9-1.02-1.23%23.16PE
Pre Market 81.85 -0.05 -0.06%
ZBHZimmer Biomet Holdings82.8-9.79-10.57%26.08PE
Pre Market 83 +0.2 +0.24%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.